Can-Fite Biopharma - 53 Year Dividend History | CANF
Historical dividend payout and yield for Can-Fite Biopharma (CANF) since 1971. The current TTM dividend payout for Can-Fite Biopharma (CANF) as of April 18, 2024 is $0.00. The current dividend yield for Can-Fite Biopharma as of April 18, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.007B |
$0.001B |
|
Can Fite Biopharma Ltd. is a biopharmaceutical company. It is focused on developing drugs for the treatment of cancer and autoimmune inflammatory diseases. The Company's lead drug candidate, CF101, is in clinical development for the treatment of autoimmune inflammatory diseases. Its CF102 drug candidate is being developed for the treatment of liver diseases and its CF602 drug is being developed for the treatment of inflammation and sexual dysfunction. Can Fite Biopharma Ltd. is based in Petach Tikva, Israel.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
